Cargando…

Agomelatine prevents angiotensin II-induced endothelial and mononuclear cell adhesion

Agomelatine is a non-selective melatonin receptor agonist and an atypical antidepressant with anti-inflammatory, neuroprotective, and cardioprotective effects. The renin-angiotensin system modulates blood pressure and vascular homeostasis. Angiotensin II (Ang II) and its receptor Ang II type I recep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Najiao, Ye, Zhirong, Lin, Yongjun, Liu, Wensen, Xu, Na, Wang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351686/ https://www.ncbi.nlm.nih.gov/pubmed/34292876 http://dx.doi.org/10.18632/aging.203299

Ejemplares similares

Agomelatine Attenuates Isoflurane-Induced Inflammation and Damage in Brain Endothelial Cells
por: Cheng, Fang, et al.
Publicado: (2020)

The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study
por: Hong, Najiao, et al.
Publicado: (2022)

Agomelatine prevents macrophage infiltration and brain endothelial cell damage in a stroke mouse model
por: Cao, Yiqiang, et al.
Publicado: (2021)

Agomelatine for postpartum depression and breastfeeding
por: Xiao, Le
Publicado: (2021)

A systematic review of agomelatine-induced liver injury
por: Freiesleben, Silka Dawn, et al.
Publicado: (2015)

Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells
por: SHI, MIAO-QIAN, et al.
Publicado: (2016)

Agomelatine: A novel melatonergic antidepressant
por: Manikandan, S
Publicado: (2010)

Efficacy and tolerability of agomelatine in the treatment of depression
por: Plesničar, Blanka Kores
Publicado: (2014)

Agomelatine Efficacy in the Night Eating Syndrome
por: Milano, Walter, et al.
Publicado: (2013)

Agomelatine Protection in an LPS-Induced Psychosis-Relevant Behavior Model
por: Inanir, Sema, et al.
Publicado: (2015)

Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease
por: Su, Qiang, et al.
Publicado: (2022)

Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2020)

Expression and clinical significance of NRLP1 in patients with ST-segment elevation myocardial infarction combined with malignant ventricular arrhythmia
por: Xie, SiXin, et al.
Publicado: (2023)

Agomelatine and its therapeutic potential in the depressed patient
por: Kennedy, Sidney H, et al.
Publicado: (2007)

Agomelatine: The evidence for its place in the treatment of depression
por: Eser, Daniela, et al.
Publicado: (2010)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Suspected Agomelatine-induced restless legs syndrome: a case report
por: Abdul Karim, Mustafa, et al.
Publicado: (2021)

The Effects of Agomelatine Treatment on Lipopolysaccharide-Induced Septic Lung Injuries in Rats
por: Köse, Duygu, et al.
Publicado: (2021)

Role of SIRT3 in Angiotensin II-induced human umbilical vein endothelial cells dysfunction
por: Liu, Hui, et al.
Publicado: (2015)

Angiotensin II Inhibits Insulin Binding to Endothelial Cells
por: Oh, Su-Jin, et al.
Publicado: (2011)

Agomelatine: relief ensured at each and every stage of depression
por: Möller, Hans-Jurgen
Publicado: (2010)

Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo
por: He, Jiayang, et al.
Publicado: (2018)

Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice
por: Nadar, Jegan Sakthivel, et al.
Publicado: (2018)

Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders
por: Savino, Rosa, et al.
Publicado: (2023)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells
por: Yao, Kai, et al.
Publicado: (2019)

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study
por: Fornaro, Michele, et al.
Publicado: (2013)

Angiotensin II Stimulates the Proliferation and Migration of Lymphatic Endothelial Cells Through Angiotensin Type 1 Receptors
por: Lin, Qiu-Yue, et al.
Publicado: (2020)

Angiotensin II mediates the high-glucose-induced endothelial-to-mesenchymal transition in human aortic endothelial cells
por: Tang, Rining, et al.
Publicado: (2010)

Endothelial-specific deletion of Ets-1 attenuates Angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition
por: Xu, Lian, et al.
Publicado: (2019)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
por: Taylor, David, et al.
Publicado: (2014)

Successful Treatment with Agomelatine in NES: A Series of Five Cases
por: Milano, W., et al.
Publicado: (2013)

Agomelatine as monotherapy for major depression: an outpatient, open-label study
por: Pecenak, Jan, et al.
Publicado: (2013)

Agomelatine in the Treatment of Major Depressive Disorder: An Assessment of Benefits and Risks
por: Gahr, Maximilian
Publicado: (2014)

Profile of agomelatine and its potential in the treatment of generalized anxiety disorder
por: Levitan, Michelle Nigri, et al.
Publicado: (2015)

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies
Publicado: (2014)

Novel Conformationally Constrained Analogues of Agomelatine as New Melatoninergic Ligands
por: Rami, Marouan, et al.
Publicado: (2012)

Evidence-Based Pharmacotherapy of Generalised Anxiety Disorder: Focus on Agomelatine
por: Stein, Dan J.
Publicado: (2021)

Evaluation of the Highly Variable Agomelatine Pharmacokinetics in Chinese Healthy Subjects to Support Bioequivalence Study
por: Pei, Qi, et al.
Publicado: (2014)

Protective Effects of Short-Chain Fatty Acids on Endothelial Dysfunction Induced by Angiotensin II
por: Robles-Vera, Iñaki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1bvega4cacksiismee82mculj6